Citation

Wang X, Blackaby W, Allen V, Chan GKY, Chang JH, Chiang PC, Diène C, Drummond J, Do S, Fan E, Harstad EB, Hodges A, Hu H, Jia W, Kofie W, Kolesnikov A, Lyssikatos JP, Ly J, Matteucci M, Moffat JG, Munugalavadla V, Murray J, Nash D, Noland CL, Del Rosario G, Ross L, Rouse C, Sharpe A, Slaga D, Sun M, Tsui V, Wallweber H, Yu SF, Ebens AJ.: Optimization of Pan-Pim Kinase Activity and Oral Bioavailability Leading to Diaminopyrazole (GDC-0339) for the Treatment of Multiple Myeloma. J Med Chem, Volume 62 (4), 2019

Authors

Allen V, Blackaby W, Chan GKY, Chang JH, Chiang PC, Del Rosario G, Diène C, Do S, Drummond J, Ebens AJ., Fan E, Harstad EB, Hodges A, Hu H, Jia W, Kofie W, Kolesnikov A, Ly J, Lyssikatos JP, Matteucci M, Moffat JG, Munugalavadla V, Murray J, Nash D, Noland CL, Ross L, Rouse C, Sharpe A, Slaga D, Sun M, Tsui V, Wallweber H, Wang X, Yu SF

Journal

J Med Chem

Year

2019

DOI

10.1021/acs.jmedchem.8b01857

PubMed

30715878

Machine-readable

REST APIRDF